Gerresheimer stock rises after JPMorgan keeps Overweight
Published on 08/30/2026 at 16:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Gerresheimer stock is trading at EUR 26.50 after JPMorgan kept its Overweight call and the latest first-quarter update showed EUR 524 million in revenue, EUR 66 million in adjusted EBITDA, and a free cash flow swing to minus EUR 32 million from minus EUR 141 million a year earlier.
The move followed the 46 euro target that JPMorgan reiterated on August 28, 2026, after the delayed first-quarter figures. That report said revenue in Q1 2026 beat expectations while operating profit was weaker because management prioritized cash generation.
Q1 2026 still mixed
Gerresheimer's Q1 2026 revenue rose to EUR 524 million from EUR 519 million, while adjusted EBITDA fell to EUR 66 million from EUR 81 million, cutting the margin to 12.6 percent from 15.7 percent. The company also said free cash flow improved by more than EUR 100 million year over year, a clear contrast with the softer profit line.
Segment detail showed the split clearly. Containment & Delivery Systems lifted revenue to EUR 296 million from EUR 281 million and raised adjusted EBITDA to EUR 61 million from EUR 52 million, while Moulded Glass slipped to EUR 144 million from EUR 160 million and its adjusted EBITDA dropped to EUR 6 million from EUR 32 million.
Cash flow matters most
The market is now weighing whether the cash focus can carry the company through the rest of 2026. Gerresheimer said it expects a stronger second half, and the reported improvement in free cash flow to minus EUR 32 million gives that view a measurable base.
A second important point is timing. The company said final quarterly numbers should follow in September 2026, and the virtual annual general meeting is set for August 31, 2026, giving investors another check-in on the plan.
Product link
Gerresheimer's portfolio spans packaging and drug-delivery systems, with syringe and injectable solutions among the groups highlighted in the first-quarter update. Those products matter because they connect revenue growth with the operating mix that is shaping margins and cash generation.
Share level
The shares were last quoted at EUR 26.50 on August 28, 2026, 10:25 p.m. ET, after the first-quarter update and the JPMorgan note. That leaves the stock far below the 46 euro target attached to the Overweight stance.
Fact box
Company: Gerresheimer AG
ISIN: DE000A0LD6E6
Ticker: GXI
Exchange: Xetra
Price (as of August 28, 2026, 10:25 p.m. ET): EUR 26.50
Sector / Industry: Health Care / Life Sciences Tools & Services
Index membership: MDAX
